Haiqing Wang is a Senior Director at Alnylam Pharmaceuticals specializing in Drug Metabolism and Pharmacokinetics (DMPK). With a Ph. D. from the University of Minnesota, her career features extensive experience in oncology and quantitative translation at Takeda. Colleagues have described her as a well-rounded and knowledgeable scientist.
She is a frequent speaker at industry symposiums, recently presenting on the evolution of First-in-Human (FIH) dose selection for biologics in oncology.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.